Trihexyphenidyl potentiation of L-DOPA: Reduced effectiveness three years later in MPTP-induced chronic hemiparkinsonian monkeys

被引:4
作者
Domino, EF [1 ]
Ni, LS [1 ]
机构
[1] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA
关键词
trihexyphenidyl; L-DOPA methyl ester; MPTP; hemiparkinsonism; monkeys;
D O I
10.1006/exnr.1998.6859
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The effects of a combination of trihexyphenidyl and L-DOPA methyl ester given i.m. were studied 3-5 years after MPTP induced hemiparkinsonism in five female adult Macaca nemistrina monkeys. Three years later, these studies were repeated to determine if the drug combination was equally effective. Although the combination of trihexyphenidyl and L-DOPA produced potentiation in both studies, 3 years later it was quantitatively less. This was due primarily to the reduced effectiveness of L-DOPA methyl ester in II dose of 12.5 mg/kg i.m. Even though the combination was less effective ire subsequent years, the animals continued to show the same clinical signs of hemiparkinsonism. Reduced effectiveness of the drug combination does not appear to be due to a lessening of MPTP-induced hemiparkinsonism, but rather to the reduced effectiveness of L-DOPA (C) 1998 Academic Press.
引用
收藏
页码:238 / 242
页数:5
相关论文
共 12 条
[1]  
BANKIEWICZ KS, 1986, LIFE SCI, V39, P7, DOI 10.1016/0024-3205(86)90431-5
[2]  
BELLENGER V, 1994, POLYM POLYM COMPOS, V2, P9
[3]   Talipexole or pramipexole combinations with chloro-APB (SKF 82958) in MPTP-induced hemiparkinsonian monkeys [J].
Domino, EF ;
Ni, LS ;
Zhang, HL ;
Kohno, Y ;
Sasa, M .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 325 (2-3) :137-144
[4]  
DOMINO EF, 1993, J PHARMACOL EXP THER, V265, P1387
[5]  
DOMINO EF, 1993, J PHARMACOL EXP THER, V264, P221
[6]  
DOMINO EF, 1998, IN PRESS JPN J PHARM
[7]  
EMBORGKNOTT ME, 1998, IN PRESS EXP NEUROL
[8]   BINDING AND FUNCTIONAL PROFILES OF THE SELECTIVE M1 MUSCARINIC RECEPTOR ANTAGONISTS TRIHEXYPHENIDYL AND DICYCLOMINE [J].
GIACHETTI, A ;
GIRALDO, E ;
LADINSKY, H ;
MONTAGNA, E .
BRITISH JOURNAL OF PHARMACOLOGY, 1986, 89 (01) :83-90
[9]  
STANDAERT DG, 1996, GOODMAN GILMANS PHAR, P503
[10]  
TIEN XY, 1985, BIOCHEM PHARMACOL, V34, P588